Cargando…
Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer
SIMPLE SUMMARY: The presence of the sodium–iodide symporter (NIS) at the plasma membrane (PM) of differentiated thyroid cancer (DTC) cells is required for the successful use of radioiodine (RAI) therapy in these malignancies. However, NIS is frequently downregulated in malignant thyroid tissue, and...
Autores principales: | Faria, Márcia, Domingues, Rita, Bugalho, Maria João, Silva, Ana Luísa, Matos, Paulo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582450/ https://www.ncbi.nlm.nih.gov/pubmed/34771624 http://dx.doi.org/10.3390/cancers13215460 |
Ejemplares similares
-
MAPK Inhibition Requires Active RAC1 Signaling to Effectively Improve Iodide Uptake by Thyroid Follicular Cells
por: Faria, Márcia, et al.
Publicado: (2021) -
Extending the Impact of RAC1b Overexpression to Follicular Thyroid Carcinomas
por: Faria, Márcia, et al.
Publicado: (2016) -
Effect of PAK Inhibition on Cell Mechanics Depends on Rac1
por: Mierke, Claudia Tanja, et al.
Publicado: (2020) -
RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells
por: Faria, Márcia, et al.
Publicado: (2017) -
CYRI/ Fam49 Proteins Represent a New Class of Rac1 Interactors
por: Whitelaw, Jamie A., et al.
Publicado: (2019)